WO2010145923A2 - Sprays anti-transpirants - Google Patents

Sprays anti-transpirants Download PDF

Info

Publication number
WO2010145923A2
WO2010145923A2 PCT/EP2010/057211 EP2010057211W WO2010145923A2 WO 2010145923 A2 WO2010145923 A2 WO 2010145923A2 EP 2010057211 W EP2010057211 W EP 2010057211W WO 2010145923 A2 WO2010145923 A2 WO 2010145923A2
Authority
WO
WIPO (PCT)
Prior art keywords
silver
acid
oil
linear
composition according
Prior art date
Application number
PCT/EP2010/057211
Other languages
German (de)
English (en)
Other versions
WO2010145923A3 (fr
Inventor
Bernhard Banowski
Imme Breuer
Barbara Heide
Gertraud Teckenbrock
Bernd Anderheggen
Original Assignee
Henkel Ag & Co. Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel Ag & Co. Kgaa filed Critical Henkel Ag & Co. Kgaa
Publication of WO2010145923A2 publication Critical patent/WO2010145923A2/fr
Publication of WO2010145923A3 publication Critical patent/WO2010145923A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/044—Suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/046—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/58—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing atoms other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur or phosphorus
    • A61K8/585—Organosilicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q15/00—Anti-perspirants or body deodorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30—Characterized by the absence of a particular group of ingredients
    • A61K2800/31—Anhydrous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/005—Antimicrobial preparations

Definitions

  • the present invention relates to anhydrous antiperspirant compositions, in particular based on an anhydrous, propellant-free sprayable or sprayable with a propellant suspension, which have an improved antiperspirant and deodorant effect.
  • Anhydrous, sprayable with a propellant antiperspirant suspensions contain in addition to sweat-reducing agents usually at least one cosmetic oil as a carrier for the particulate sweat-reducing agent.
  • the supensions are filled in a pressure-resistant container, usually a can of tinplate or aluminum, which is painted inside, together with a liquefied hydrocarbon, such as n-butane, isobutane and / or propane, as a propellant.
  • a liquefied hydrocarbon such as n-butane, isobutane and / or propane
  • a phyllosilicate especially talc or hectorites, which may be hydrophobically modified, as obtainable, for example, under the trade name Bentone Gel from Rheox and Elementis Speciales ,
  • Such antiperspirant active compensates for product performance losses due to wetting of the antiperspirant active with the oil carrier and thereby retarded Release on the skin can arise.
  • the gelation process of the layered silicate suspending agent must be started by adding a certain amount of polar liquid, for example ethanol, propylene carbonate or ethanol / propylene carbonate mixtures.
  • polar liquid for example ethanol, propylene carbonate or ethanol / propylene carbonate mixtures.
  • Antiperspirant sprays are known in the art, for example from US 5368842, which teach a mixture of hydrophilic colloidal silica and hydrophobic colloidal silica as an alternative to hydrophobically modified hectorite suspending agent, said composition not containing any polar liquid, especially ethanol ,
  • the antimicrobial action of silver salts and complex silver salts, here preferably silver citrate complexes, and the use of such compounds in cosmetic compositions is known in the art, see for example US 20060051430 A1 and US 200601 15440 A1.
  • Some of such silver salts and complex silver salts which have been found to be particularly suitable can not be completely free of polar impurities such as water, ethanol or excess acid.
  • antiperspirant sprays containing a mixture of hydrophilic colloidal silica and hydrophobic colloidal silica as suspending agent can be formulated in a storage-stable manner with silver salts and complex silver salts containing polar admixtures, such as water, ethanol or excess acid, if the total amount of phyllosilicates, in particular of talcum and hectorite, is from zero to at most 1.3% by weight, preferably from zero to at most 1% by weight, more preferably from zero to at most 0.5% by weight, based on the total weight the blowing agent-free composition is.
  • polar admixtures such as water, ethanol or excess acid
  • the present invention therefore provides antiperspirant compositions for personal care, formulated as a propellant-free or sprayable with a propellant suspension or solution containing at least one antiperspirant active, at least one liquid under normal conditions as a carrier, a mixture of hydrophilic and hydrophobic silica as a suspending agent - 6 wt .-% of free water, based on the weight of the propellant-free composition, at least one silver salt, layered silicate (s) in a total amount of zero to a maximum of 1, 3 wt .-%.
  • antiperspirant compositions according to the invention on an anhydrous basis are formulated as propellant-free, for example in a pump dispenser, or sprayed with a propellant suspension or solution.
  • the antiperspirant active substance combination according to the invention is preferably suitable for sprayable ready-to-use compositions, in particular for propellant-containing suspensions which are used as an antiperspirant spray.
  • normal conditions are a temperature of 20 ° C. and a pressure of 1013.25 mbar. Melting point data likewise refer to a pressure of 1013.25 mbar.
  • Hydrophilic silicas used according to the invention are slightly wetted with water.
  • compositions preferred according to the invention are characterized in that at least one hydrophilic silica is present in a total amount of 0.2-2% by weight, preferably 0.4. 1, 5 wt .-%, more preferably 0.5 to 1, 0 wt .-% and most preferably 0.6 to 0.8 wt .-%, each based on the total weight of the propellant-free composition of the invention is included.
  • Hydrophobic silicas used according to the invention are alkyl-modified at least on the surface of the silica particles. They preferably contain hydrophobic groups on the surface, such as (CH 3 ) 3 Si-O-, (-Si (CH 3 ) 2 O-) n ,
  • Preferred hydrophobic silicas are hydrophobic fumed silicas, particularly the alkylated commercial products of Aerosil ® series of Degussa, in particular Aerosil ® - R202, Aerosil ® -R805, -R812 Aerosil ®, Aerosil ® -R972 and Aerosil ® -R976, besides also products the Cab-O-Sil TS series by Cabot, especially Cab-O-Sil TS-530.
  • hydrophobic silicas are silica silylates and silica dimethyl silylates. Also particularly preferred is Aerosil ® -R972, having a BET surface area of about 110 m 2 / g and about 70% of the surface occupied with methylated hydroxyl groups.
  • Compositions which are preferred according to the invention are characterized in that at least one hydrophobic silica is present in a total amount of 1-5% by weight, preferably 1.5-4% by weight, more preferably 2-3.5% by weight, most preferably 2% , 5 - 3 wt .-%, each based on the total weight of the propellant-free composition of the invention is included.
  • compositions according to the invention are characterized in that they contain layer silicate (s) in a total amount of zero to at most 1.3% by weight, preferably zero to at most 1% by weight, more preferably zero to a maximum of 0.5% by weight. %, based on the total weight of the propellant-free composition.
  • sheet silicates includes in particular talc, soapstone, clay minerals such as montmorillonites, nontronites, hectorites, bentonites, in particular disteardimonium hectorites and quaternium-18 hectorites, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite and sepiolite.
  • clay minerals such as montmorillonites, nontronites, hectorites, bentonites, in particular disteardimonium hectorites and quaternium-18 hectorites, saponite, sauconite, beidellite, allevardite, illite, halloysite, attapulgite and sepiolite.
  • compositions according to the invention are characterized in that they contain at least one silver salt.
  • the silver salt is selected from the Ag + salts of at least one acid selected from alpha-hydroxycarboxylic acids, beta-hydroxycarboxylic acids, alpha- keto carboxylic acids, acetic acid, sulfuric acid and hydrochloric acid.
  • alpha-hydroxycarboxylic acids and .beta.-hydroxycarboxylic acids are selected from glycolic acid, lactic acid, tartaric acid, citric acid, 2-hydroxybutanoic acid, 2,3-dihydroxypropanoic acid, 2-hydroxypentanoic acid, 2-hydroxyhexanoic acid, 2-hydroxyheptane acid, 2-hydroxyoctanoic acid, 2-hydroxydecanoic acid, 2-hydroxydodecanoic acid, 2-hydroxytetracenecanoic acid, 2-hydroxyhexadecanoic acid, 2-hydroxyoctadecanoic acid, mandelic acid, 4-hydroxymandelic acid, malic acid, erythraric acid, threaric acid, glucaric acid, galactaric acid, mannaric acid, gular acid, 2-hydroxy-2-methylsuccinic acid, gluconic acid, pyruvic acid, glucuronic acid and galacturonic acid.
  • Particularly preferred ⁇ -hydroxycarboxylic acids
  • compositions according to the invention are characterized in that the silver salt is selected from silver citrate, silver lactate, silver glycolate, silver tartrate, silver malate, silver gluconate, silver glucuronate, silver mandelate, silver pyruvate, silver salicylate, silver acetate, silver sulfate and silver chloride. Extraordinary preference is given to silver citrate. Furthermore, silver lactate is very preferred.
  • compositions preferred according to the invention are characterized in that at least one silver salt in a total amount of 0.00001-0.5 wt.%, Preferably 0.0001-0.1 wt.%, Particularly preferably 0.001-0.05 wt. %, most preferably 0.005 to 0.01 wt .-%, each based on the total weight of the propellant-free composition according to the invention is included.
  • compositions according to the invention contain at least one antiperspirant active substance.
  • Preferred antiperspirant active ingredients are selected from the water-soluble astringent inorganic and organic salts of aluminum and zinc or any desired mixtures of these salts.
  • solubility of at least 5 wt .-% at 20 0 C is understood according to the invention, solubility in water, that is, amounts of at least 5 g of the antiperspirant active ingredient in 95 g of water are soluble at 20 0 C.
  • antiperspirant active ingredients are selected from aluminum chlorohydrate, in particular aluminum chlorohydrate having the general formula [Al 2 (OH) 5 Cl. 1-6 H 2 O] n , preferably [Al 2 (OH) 5 Cl. 2-3 H 2 O. ] n , which may be in non-activated or in activated (depolymerized) form, and aluminum chlorohydrate having the general formula [Al 2 (OH) 4 Cl 2 ⁇ 1-6 H 2 O] n , preferably [Al 2 (OH) 4 CI 2 ⁇ 2-3 H 2 O] n , which may be in unactivated or activated (depolymerized) form.
  • aluminum sesquichlorohydrate aluminum dichlorohydrate, aluminum chlorohydrex-propylene glycol (PG) or aluminum chlorohydrex-polyethylene glycol (PEG), aluminum glycol complexes, e.g. Aluminum-propylene glycol complexes, aluminum sesquichlorohydrex PG or aluminum sesquichlorohydrex PEG, aluminum PG-dichlorohydrex or aluminum PEG- dichlorohydrex, aluminum hydroxide, further selected from potassium aluminum sulfate (KAl (SO 4 ) 2 .12H 2 O, alum), aluminum undecylenoylcollagenanninoic acid, sodium aluminum lactate + aluminum sulphate, sodium aluminum chlorohydroxactate, aluminum bromohydrate, aluminum chloride, the complexes of zinc and sodium salts, the aluminum salts of lipoamino acids , Aluminum sulfate, aluminum lactate, aluminum chlorohydrate, sodium alumina chlorohydroxy lactate, zinc chloride, zinc sulfo
  • antiperspirant active ingredients are selected from what are known as “activated” aluminum salts, which are also referred to as “antiperspirant active ingredients” having enhanced activity (English: enhanced activity).
  • activated aluminum salts are typically produced by heat treating a relatively dilute solution of the salt (e.g., about 10% by weight of salt) to increase its HPLC peak 4-to-peak 3 area ratio.
  • the activated salt can then be dried to a powder, in particular spray-dried. In addition to the spray drying z. B. also suitable for drum drying.
  • Activated aluminum salts typically have a HPLC peak 4-to-peak 3 area ratio of at least 0.4, preferably at least 0.7, more preferably at least 0.9, with at least 70% of the aluminum attributable to these peaks.
  • Antiperspirant active ingredients which are likewise preferred according to the invention are nonaqueous solutions or solubilisates of an activated antiperspirant aluminum salt, for example according to US Pat. No. 6,010,688, which comprises adding an effective amount of a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably propylene glycol , Sorbitol and pentaerythritol, are stabilized against the loss of activation against the rapid degradation of the HPLC peak 4: peak 3 area ratio of the salt.
  • a polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups preferably propylene glycol , Sorbitol and pentaerythritol
  • compositions containing by weight 18-45% by weight of an activated aluminum salt, 55-82% by weight of at least one anhydrous polyhydric alcohol of 3 to 6 carbon atoms and 3 to 6 hydroxyl groups, preferably Propylene glycol, butylene glycol, diethylene glycol, dipropylene glycol, glycerin, sorbitol and pentaerythritol, more preferably propylene glycol.
  • complexes of activated antiperspirant aluminum salts with a polyhydric alcohol containing from 20 to 50% by weight, more preferably from 20 to 42% by weight, of activated antiperspirant aluminum salt and from 2 to 16% by weight of molecularly bound water; Rest to 100 wt .-% of at least one polyhydric alcohol having 3 to 6 carbon atoms and 3 to 6 hydroxyl groups.
  • Propylene glycol, propylene glycol / sorbitol mixtures and propylene glycol / pentaerythritol mixtures are preferred such alcohols.
  • Such inventions According to the preferred complexes of an activated antiperspirant aluminum salt with a polyhydric alcohol are z.
  • Other preferred antiperspirant actives are basic calcium aluminum salts, as disclosed, for example, in US 2571030. These salts are prepared by reacting calcium carbonate with aluminum chlorhydroxide or aluminum chloride and aluminum powder or by adding calcium chloride dihydrate to aluminum chlorhydroxide. Further preferred antiperspirant active compounds are activated aluminum salts, as disclosed, for example, in US Pat. No. 6,245,325 or US Pat. No.
  • USP 5-78% by weight
  • Particularly preferred solid activated antiperspirant salt compositions for example according to US Pat. No. 6,245,325 or US Pat. No. 6,042,816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4%. 13 wt .-% molecularly bound water (water of hydration), further sufficient water-soluble calcium salt that the Ca: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to (Al + Zr) - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water (water of hydration), further so much water-soluble calcium salt that the Ca: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much glycine that the glycine to Al - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • an activated aluminum salt and 1-16% by weight preferably 4 - 13 wt .-% molecularly bound water (water of hydration)
  • water of hydration water of hydration
  • solid antiperspirant activated salt compositions for example according to US 6245325 or US 6042816, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4 - 13 wt .-% molecularly bound water, further so much water-soluble calcium salt that the Ca: AI weight ratio 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much hydroxyalkanoic that the hydroxyalkanoic acid to AI - Weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • Preferred water-soluble calcium salts for the stabilization of antiperspirant salts are selected from calcium chloride, calcium bromide, calcium nitrate, calcium citrate, calcium formate, calcium acetate, calcium gluconate, calcium ascorbate, calcium lactate, calcium glycinate, calcium carbonate, calcium sulfate, calcium hydroxide, and mixtures thereof.
  • Preferred amino acids for the stabilization of the antiperspirant salts are selected from glycine, alanine, leucine, isoleucine, ⁇ -alanine, VaNn, cysteine, serine, tryptophan, phenylalanine, methionine, ⁇ -amino-n-butanoic acid and ⁇ -amino-n-butanoic acid and the salts thereof, each in the d-form, the I-form and the dl-form; Glycine is particularly preferred.
  • Preferred hydroxyalkanoic acids for the stabilization of the antiperspirant salts are selected from glycolic acid and lactic acid.
  • activated aluminum salts such as disclosed in US 6902723, containing 5-78% by weight (USP) of an activated antiperspirant aluminum salt, an amino acid or hydroxyalkanoic acid in such amount as to add (amino acid or hydroxyalkanoic acid) Al - weight ratio of 2: 1 - 1: 20 and preferably 1: 1 to 1:10, and a water-soluble strontium salt in such an amount to have a Sr: Al weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25.
  • USP activated aluminum salts
  • an amino acid or hydroxyalkanoic acid in such amount as to add (amino acid or hydroxyalkanoic acid) Al - weight ratio of 2: 1 - 1: 20 and preferably 1: 1 to 1:10
  • a water-soluble strontium salt in such an amount to have a Sr: Al weight ratio of 1: 1 - 1:28 and preferably 1: 2 - 1: 25.
  • Particularly preferred solid antiperspirant activated salt compositions contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight. -% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: Al weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to AI - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • USP 48-78% by weight
  • -% molecularly bound water, further enough so much water-soluble strontium salt that the Sr: Al weight ratio is 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and so much amino acid that the amino acid to AI - weight ratio 2: 1 - 1: 20, preferably 1: 1 - 1: 10, is.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight .-% molecularly bound water, further so much water-soluble strontium salt that the Sr: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much glycine that the glycine to Al - weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • solid antiperspirant activated salt compositions for example according to US 6902723, contain 48-78% by weight (USP), preferably 66-75% by weight of an activated aluminum salt and 1-16% by weight, preferably 4-13% by weight .-% molecularly bound water, further so much water-soluble strontium salt that the Sr: Al weight ratio of 1: 1 - 1: 28, preferably 1: 2 - 1: 25, and is so much hydroxyalkanoic that the hydroxyalkanoic acid to Al - weight ratio 2: 1-1: 20, preferably 1: 1-1: 10.
  • Further preferred activated aluminum salts are those of the general formula Al 2 (OH) 6 .
  • Xa a Xa
  • X is Cl, Br, I or NO 3 and "a" is a value of 0.3 to 5, preferably from 0.8 to 2.5 and particularly preferably 1 to 2, so that the molar ratio of Al X is 0.9: 1 to 2.1: 1, as disclosed, for example, in US 6074632.
  • These salts generally associate some hydration water, typically 1 to 6 moles of water per mole of salt.
  • Particularly preferred is aluminum chlorohydrate (ie X is Cl in the aforementioned formula) and especially 5/6 basic aluminum chlorohydrate, wherein "a” is 1, so that the molar ratio of aluminum to chlorine is 1.9: 1 to 2.1: 1.
  • the antiperspirant active ingredients can be present both in solubilized and in undissolved, suspended form.
  • the active ingredient particles have a number average particle size of 0.1-200 .mu.m, preferably 1-50 .mu.m, particularly preferably 3-20 .mu.m and extraordinarily preferably 5 - 10 microns have.
  • Preferred active substance particles have a volume-average particle size of 0.2-220 .mu.m, preferably 3-60 .mu.m, more preferably 4-25 .mu.m, more preferably 5-20 .mu.m and most preferably 10-15.5 .mu.m.
  • Preferred aluminum salts have a molar metal-to-chloride ratio of 1.9-2.1, or for sesquichlorohydrates of 1, 5: 1-1, 8: 1.
  • the antiperspirant active compounds can be used as nonaqueous solutions or as glycolic solubilisates.
  • compositions according to the invention are characterized in that the at least one antiperspirant active ingredient is present in an amount of 5 to 40% by weight, preferably 10 to 35% by weight, more preferably 11 to 28% by weight and most preferably 12%. 20 wt .-%, based on the total weight of the water-free active substance (USP) in the blowing agent-free total composition.
  • USP water-free active substance
  • the composition contains an astringent aluminum salt, in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • an astringent aluminum salt in particular aluminum chlorohydrate, more preferably aluminum chlorohydrate with an anhydrous active substance (USP) of 72-88 wt .-%, based on the raw material tel quel.
  • Preferred non-activated aluminum chlorohydrates for example, in powder form as Micro Dry ®, Micro Dry ® Ultrafine or Micro Dry ® -323 from Summit / Reheis, as Chlorhydrol ® (powder) as well as in activated form as Reach ® 101, Reach ® 103, Reach ® 501 from Reheis / Summit or AACH-7171 from Summit. Under the name Reach® 301 an aluminum sesquichlorohydrate from Reheis is offered, which is likewise particularly preferred.
  • compositions of the invention contain at least one oil as a carrier fluid.
  • Antiperspirant compositions preferred according to the invention contain from 30 to 95% by weight, preferably from 40 to 93% by weight, more preferably from 50 to 90% by weight, most preferably from 55 to 85% by weight, based in each case on the entire blowing agent-free composition , on at least one liquid cosmetic liquid under normal conditions.
  • a total amount of liquid cosmetic oils of 60, 63, 65, 68, 70, 73, 75, 78 or 80% by weight, based in each case on the total blowing agent-free composition can also be used according to the invention. According to particularly preferred, wherein a total amount of 68 - 73 wt .-% is particularly preferred.
  • Non-volatile oils are understood to mean those oils which have a vapor pressure of less than 2.66 Pa (0.02 mm Hg) at 20 ° C. and an ambient pressure of 1013 hPa.
  • Volatile oils are understood as meaning those oils which, at 20 ° C. and an ambient pressure of 1013 hPa, have a vapor pressure of 2.66 Pa-40,000 Pa (0.02 mm-300 mm Hg), preferably 13-12,000 Pa (0.1- 90 mm Hg), more preferably 15-8000 Pa, most preferably 300-3000 Pa.
  • Cosmetic oils preferred according to the invention are selected from silicone oils, to which z.
  • dialkyl and alkylaryl such as cyclopentasiloxane, cyclohexasiloxane, dimethyl polysiloxane, low molecular weight phenyl trimethicone and Methylphenylpolysiloxan, but also include hexamethyldisiloxane, octamethyltrisiloxane and decamethyltetrasiloxane.
  • Particularly preferred are volatile silicone oils, which may be cyclic, such as.
  • B. Octamethylcyclotetrasil- oxane, decamethylcyclopentasiloxane and Dodecamethylcyclohexasiloxan and mixtures thereof, as described, for. B.
  • volatile linear silicone oils having 2 to 10 siloxane units, in particular hexamethyldisiloxane (L 2 ), octamethyltrisiloxane (L 3 ), decamethyltetrasiloxane (L 4 ) and any mixtures of two and three of L 2 , L 3 and / or L 4 such mixtures, as they are for.
  • Another preferred volatile silicone oil is a low molecular weight phenyl trimethicone having a vapor pressure at 2O 0 C of about 2000 Pa, as available for example from GE Bayer Silicones / Momentive under the name Baysilone Fluid PD 5.
  • Volatile silicone oils are excellently suitable carrier oils for antiperspirant compositions which are preferred according to the invention, since they give them a pleasant feel on the skin and a low level of clothes soiling.
  • Antiperspirant compositions which are particularly preferred according to the invention are therefore based on a content of at least one volatile silicone oil of 30-95% by weight, preferably 40-93% by weight, particularly preferably 50-90% by weight, very preferably 55%. 85 wt .-%, each based on the total propellant-free composition characterized.
  • At least one volatile non-silicone oil may also be present.
  • Preferred volatile non-silicone oils are selected from C 8 -C 16 isoparaffins, in particular from isodecane, isoundecane, isododecane, isotridecane, isotetradecan, isopentadecane, and isohexadecane, and mixtures thereof.
  • Isoparaffin mixtures especially those having a vapor pressure at 2O 0 C of about 300 - - 400 Pa, preferably 360 Pa C 10 -C 13 are preferred.
  • This at least one volatile non-silicone oil is also preferred in a total amount of 30-95 wt.%, Preferably 40-93 wt.%, Particularly preferably 50-90 Wt .-%, most preferably 55 to 85 wt .-%, each based on the total propellant-free composition.
  • the carrier oil used are volatile silicone oils, isoparaffins, especially isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane, as well as mixtures of volatile silicone oils and isoparaffins, especially isododecane, isohexadecane or isoeicosan , especially preferred.
  • compositions according to the invention are characterized in that the at least one carrier oil b) which is liquid under normal conditions comprises at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane.
  • the at least one carrier oil b) which is liquid under normal conditions comprises at least one isoparaffin oil, in particular isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosane.
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions b) is a mixture of b) i) a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units, and b) ii) at least one isoparaffin oil, isodecane, isoundecane, isododecane, isotridecane, isotetradecane, isopentadecane, isohexadecane and isoeicosan.
  • the carrier oil which is liquid under normal conditions b) is a mixture of b) i) a volatile silicone oil selected from cyclomethicones and linear polydimethylsiloxanes having 2-10 siloxane units, and b) ii) at least one isoparaffin oil, isodecane, isoundecane, isododecane, isotridecane, isotetradecane
  • particularly preferred antiperspirant compositions according to the invention may further contain at least one nonvolatile cosmetic oil selected from nonvolatile silicone oils and non-volatile non-silicone oils Due to the relatively rapid evaporation of the volatile oils, solid, insoluble constituents, in particular the antiperspirant active ingredients, may be visible on the skin as an unattractive residue These residues can be successfully masked with a non-volatile oil In addition, with a mixture of non-volatile and volatile oil parameters such as skin feel, visibility of the residue s and stability of the suspension are fine-tuned and better adapted to the needs of consumers.
  • anhydrous antiperspirant compositions according to the invention with a low content of volatile oils or even without volatile oils.
  • the Esteröle 2-ethylhexyl palmitate e.g., soft Cege- ® C.
  • ester oils are particularly preferably 2-ethyl hexylpalmitat (z. B. Cegesoft ® C 24), hexyldecyl laurate, 2-ethylhexyl stearate, isopropyl myristate,
  • Preferred nonvolatile silicone oils are selected from higher molecular weight linear dimethyl polysiloxanes, commercially available for.
  • Dow Corning® 190 Dow Corning®
  • Silicone oils which are likewise preferred according to the invention are selected from silicones of the formula
  • a preferred silicone oil of formula (Sil-1) is available under the INCI name Phenyl Trimethicone in various grades, viscosities and volatilities.
  • a non-volatile phenyl trimethicone is available, for example, from Dow Corning under the name Dow Corning 556.
  • Natural and synthetic hydrocarbons such as paraffin oils, C 8 -C 30 -lsoparaf- fine, especially isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004G available from Nestle are, as well as 1, 3-di- (2-ethylhexyl) -cyclohexane (obtainable, for. example, under the trade name Cetiol ® S from Cognis) also belong to the present invention the preferred non-volatile non-silicone oils.
  • paraffin oils C 8 -C 30 -lsoparaf- fine, especially isoeicosane, polyisobutenes or polydecenes, the ®, for example, under the designation Emery ® 3004, 3006, 3010 or under the name Ethylflo ® from Albemarle or Nexbase 2004
  • non-volatile non-silicone oils are selected from the benzoic acid esters of linear or branched C 8-22 alkanols. Particularly preferred are benzoic C12-C15 alkyl esters, z. B. available as a commercial product Finsolv ® TN, benzoic isostearylester, z. B. available as a commercial product Finsolv ® SB, ethylhexyl benzoate, z. B. available as a commercial product Finsolv ® EB, and benzoic acid octyldocecylester, z. B. available as a commercial product Finsolv ® BOD.
  • non-volatile non-silicone oils which are preferred according to the invention are selected from branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms. These alcohols are also often referred to as Guerbet alcohols, as they are obtainable by the Guerbet reaction.
  • Preferred alcohol oils are Hexyldecanol (Eutanol ® G 16, Guerbitol ® T 16), octyl dodecanol (Eutanol ® G, Guerbitol ® 20), 2-ethylhexyl alcohol and the commercial products Guerbitol ® 18, Isofol ® 12, Isofol ® 16, Isofol ® 24 , Isofol ® 36, Isocarb 12 ®, ® Isocarb 16 or Isocarb ® 24.
  • Non-volatile non-silicone oils are chosen from mixtures of Guerbet alcohols and Guerbet alcohol esters, for example the commercial product Cetiol ® PGL (hexyldecanol and hexyldecyl laurate).
  • non-volatile non-silicone oils are chosen from the triglycerides of linear or branched, saturated or unsaturated, optionally hydro- xyl exig C 8 - 3 o-fatty acids.
  • Particularly suitable may be the use of natural oils, for example soybean oil, cottonseed oil, sunflower oil, palm oil, palm kernel oil, linseed oil, almond oil, castor oil, corn oil, rapeseed oil, olive oil, sesame oil, thistle oil, wheat germ oil, peach kernel oil and the liquid portions of coconut oil and the like.
  • synthetic triglyceride oils in particular Capric / Caprylic triglycerides, z.
  • Myritol ® 318 Myritol ® 331 (Cognis) or Miglyol ® 812 (Hüls) with unbranched fatty acid residues and glyceryl triisostearin
  • Estol ® GTEH 3609 Uniqema
  • Myritol ® GTEH Cognis
  • non-volatile non-silicone oils are selected from the dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols, especially diisopropyl adipate, di-n-butyl adipate, di- (2-ethylhexyl) adipate, dioctyl adipate, diethyl / di-n- butyl / dioctyl sebacate, diisopropyl sebacate, dioctyl malate, dioctyl maleate, dicaprylyl maleate, diisooctyl succinate, di-2-ethylhexyl succinate and di (2-hexyldecyl) succinate.
  • dicarboxylic acid esters of linear or branched C 2 -C 0 alkanols especially diisopropyl adipate, di-n-butyl adipate, di- (2-eth
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the esters of linear or branched saturated or non-volatile non-silicone oils unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated.
  • isopropyl palmitate isopropyl stearate, isopropyl myristate, hexyldecyl stearate (Eutanol ® G 16 S), hexyldecyl laurate, isononyl isononanoate, 2-ethylhexyl palmitate (Cegesoft ® C 24) and 2-ethylhexyl stearate (Cetiol ® 868).
  • non-volatile non-silicone oils are selected from the adducts of 1 to 5 propylene oxide units of mono- or polyhydric Cs- 22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • mono- or polyhydric Cs- 22 alkanols such as octanol, decanol, decanediol, lauryl alcohol, myristyl alcohol and stearyl alcohol, eg. B. PPG-2 myristyl ether and PPG-3 myristyl ether (Witconol APM ®).
  • non-volatile non-silicone oils which are particularly preferred according to the invention are selected from the adducts of at least 6 ethylene oxide and / or propylene oxide units with monovalent or polyvalent C 3 . 22 -alkanols such as glycerol, butanol, butanediol, myristyl alcohol and stearyl alcohol, which may be esterified if desired, for.
  • PPG-14 butyl ether (Ucon Fluid ® AP), PPG-9-butyl ether (Breox B25 ®), PPG-10 butanediol (Macol ® 57), PPG-15 stearyl ether (Arlamol ® E), and Glycereth-7 -diisononanoat.
  • non-volatile non-silicone oils are selected from the symmetrical, asymmetrical or cyclic esters of carbonic acid with fatty alcohols, eg. As glycerol carbonate, dicaprylyl (Cetiol ® CC) or the esters according to the teaching of DE 19756454 A1.
  • compositions according to the invention are characterized in that the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils, volatile hydrocarbon oils, branched saturated or unsaturated fatty alcohols having 6 to 30 carbon atoms, triglycerides of linear or branched, saturated or unsaturated, optionally hydroxylated C 8 - 3 o-fatty acids, dicarboxylic acid esters of linear or branched C 2 -C 10 -alkanols, esters of branched saturated or unsaturated fatty alcohols having 2 to 30 carbon atoms with linear or branched saturated or unsaturated fatty acids having 2 to 30 carbon atoms which may be hydroxylated, addition products 1-5 propylene oxide units onto mono- or polyhydric C 8-22 alkanols, addition products of at least 6 ethylene oxide and / or propylene oxide units onto mono- or polyhydric C.
  • the carrier oil which is liquid under normal conditions is selected from volatile silicone oils, nonvolatile silicone oils,
  • oils may be extraordinarily preferred according to the invention to use mixtures of the abovementioned oils in order to achieve optimum fine-tuning of the product properties, in particular the residue behavior, the feel of the skin or the release of the active ingredient.
  • Further oil component types which are particularly preferred according to the invention are isoparaffin oils, in particular isododecane, isohexadecane and isoeicosane. Isododecane, Isohexadecane and Isoeicosan are among the volatile oil components. Since they evaporate relatively quickly after application to the skin, the hydrophobic loading of the antiperspirant active ingredient particles is reduced. Such volatile oil components thus assist the release of the antiperspirant active.
  • compositions according to the invention are characterized in that at least one oil in a total amount of 30-80 wt .-%, preferably 40-75 wt .-%, particularly preferably in a total amount of 50-73 wt .-%, most preferably in a total amount of 56-70 wt .-%, in each case based on the total weight of the (propellant-free) composition.
  • compositions according to the invention which are applied as a spray, preferably depends on the requirements of the desired spray application.
  • the compositions of the invention are present as a suspension, that is, the antiperspirant active ingredient and optionally further insoluble constituents are suspended in a liquid carrier. Such a disperse system should be shaken before use.
  • the compositions according to the invention are formulated as a suspension which can be sprayed with a propellant.
  • Preferred compositions of the invention may, for. B. in pump or squeeze dispensers, especially in multi-chamber pump or squeeze dispensers.
  • Such donors use air, in particular the ambient air, as a propellant or promote the composition of the invention by pumping.
  • the composition is applied by means of a compressed or liquefied propellant.
  • the packaging in a multi-chamber dispenser offers special technical advantages.
  • the multi-chamber dispenser can also be used so that one chamber is filled with the composition according to the invention, while another chamber contains the compressed propellant.
  • Such a multi-chamber dispenser is, for example, a so-called bag-n-can packaging.
  • both chambers can also be connected to one another in such a way that the composition according to the invention is separated into two partial compositions, which at the same time originate from the Packaging can be issued, for example, from separate openings or from a single opening.
  • compositions according to the invention are characterized in that they are packaged with at least one propellant in a suitable pressure vessel.
  • Propellants propellant gases
  • Propellant gases which are preferred according to the invention are selected from propane, propene, n-butane, isobutane, isobutene, n-pentane, pentene, isopentane, isopentene, methane, ethane, dimethyl ether, nitrogen, air , Oxygen, nitrous oxide, dichlorofluoromethane, chlorodifluoromethane, chlorofluoromethane, 1, 1, 2,2-tetrachloro-1-fluoroethane, 1, 1, 1, 2-tetrachloro-2-fluoroethane, 1, 2,2-trichloro-1, 1 -difluoro-ethane, 1, 1, 2-trichloro-1, 2-difluoroethane, 1, 1, 1-trichloro-2,2-difluoroethane, 2,
  • hydrophilic propellants such as carbon dioxide
  • hydrophilic propellants such as carbon dioxide
  • lipophilic propellant gas eg., Propane / butane
  • propane, n-butane, isobutane and mixtures of these propellants propane, n-butane, isobutane and mixtures of these propellants. It has been found that the use of n-butane as the only propellant gas according to the invention can be particularly preferred.
  • the amount of the blowing agent is preferably 20-95% by weight, more preferably 30-90% by weight and most preferably 60-86% by weight, and still more preferably 75-78% by weight, based in each case on the Total weight of the preparation consisting of the suspension according to the invention and the propellant.
  • An inner protective lacquer which is preferred according to the invention is an epoxy-phenolic lacquer, which is obtainable, inter alia, under the name Hoba 7407 P.
  • the valves used on an internally painted valve disc wherein the coating and valve material are compatible with each other. If aluminum valves are used, their valve plates can be internally z. B. be coated with Micoflex paint. Are tinplate valves according to the invention used, so the valve plate inside z. B. be coated with PET (polyethylene terephthalate).
  • compositions according to the invention are characterized in that they contain at least one perfume.
  • perfume oils individual fragrance compounds, e.g. the synthetic products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type are used.
  • the phenolic fragrance compounds include z. B. carvacrol. Fragrance compounds of the ester type are known e.g.
  • the ethers include, for example, benzyl ethyl ether, to the aldehydes e.g. the linear alkanals having 8 to 18 C atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamen aldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones, e.g.
  • 6-acetyl-1,1,1,4,4,6-hexamethyltetrahydronaphthalene para-t-amylcyclohexanone, 2-n-heptylcyclopentanone, ⁇ -methylnaphthyl ketone and the ionones ⁇ -isomethyl-ionone and methyl cedryl ketone, to the alcohols cinnamyl alcohol, anethole , Citronellol, Dimyrcetol, Eugenol, Geraniol, Linalool, Phenylethylalcohol and Terpineol, the hydrocarbons include 1.SA ⁇ J. ⁇ -Hexahydro ⁇ ⁇ . ⁇ J. ⁇ . ⁇ -hexamethylcyclopenta-a ⁇ -benzopyran, hydroxymethylisopropylcyclopentane, 3-a- Methyldodecahydro-6,6,9a-trimethylnaphtho-2 (2,1-b) furan, is
  • Suitable perfume oils may also contain natural fragrance mixtures such as are available from plant or animal sources, e.g. Pine, citrus, jasmine, rose, lily or ylang-ylang oil.
  • lower volatility volatile oils which are most commonly used as aroma components, are useful as perfume oils, e.g. Sage oil, chamomile oil, lemon balm oil, mint oil, cinnamon leaf oil, lime blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, laudanum oil, clove oil, iso-eugenol, thyme oil, bergamot oil, geranium oil and rose oil.
  • compositions according to the invention are characterized in that at least one perfume in a total amount of 0.1 to 10 wt .-%, preferably 0.2 to 7 wt .-%, particularly preferably 0.4 to 6 wt .-%, most preferably 1 to 5% by weight, furthermore very preferably 2 to 4% by weight, in each case based on the total weight of the blowing agent-free composition.
  • compositions are characterized by a content of at least one so-called "skin-cooling agent".
  • skin-cooling active ingredients are understood as meaning active ingredients which, when applied to the skin, are a result of surface anesthetization and irritation of the cold-sensitive nerves Migraines and the like produce a pleasant feeling of cold, even if the treated skin areas actually show normal or elevated temperature.
  • Preferred skin-cooling agents are, in particular, menthol, isopulegol and menthol derivatives, eg. Menthyl lactyl, menthyl pyrrolidone carboxylic acid, menthyl methyl ether, menthoxy propane diol, menthone glycerol acetal (9-methyl-6- (1-methylethyl) -1, 4-dioxaspiro (4.5) decane-2-methanol), monomethyl succinate and 2-hydroxymethyl-3,5 , 5-trimethylcyclohexanol.
  • Particularly preferred skin-cooling active ingredients are menthol, isopulegol, menthyl lactate, menthoxypropanediol and menthylpyrrolidonecarboxylic acid.
  • compositions according to the invention contain at least one skin-cooling active ingredient in total amounts of 0.01-1% by weight, preferably 0.02-0.5% by weight and more preferably 0.05-0.2% by weight, in each case based on on the total weight of the (propellant-free) composition.
  • compositions according to the invention are characterized in that at least one encapsulated active ingredient is contained.
  • active substances which may be advantageously encapsulated, are in particular fragrances, perfume oils and / or skin-cooling active ingredients, but also other skin-care active substances, such as vitamins, antioxidants, etc.
  • Preferred capsule material are water-soluble polymers such as starch, physically and / or chemically modified starches, cellulose derivatives, such as. As carboxymethylcellulose, methylcellulose, hydroxyethylcellulose or hydroxypropylmethylcellulose, carrageenans, alginates, maltodextrins, dextrins, vegetable gums, pectins, xanthans, polyvinyl acetate and polyvinyl alcohol, polyvinylpyrrolidine, polyamides, polyesters and homopolymers and copolymers of monomers selected from acrylic acid, methacrylic acid , Maleic acid, fumaric acid, itaconic acid and the esters and the salts of these acids, as well as any mixtures of these polymers.
  • cellulose derivatives such as.
  • Preferred capsule materials are chemically modified starches, in particular aluminum starch octenylsuccinate, eg.
  • aluminum starch octenylsuccinate eg.
  • the commercial product Dry FIo Plus from National Starch
  • sodium starch octenylsuccinate eg.
  • the commercial product Capsul from National Starch further carboxymethylcellulose, carboxymethylcellulose, methylcellulose, hydroxyethylcellulose and hydroxypropylmethylcellulose, ethylcellulose, e.g.
  • the commercial product Tylose H 10 from Clariant continue Carragheene, alginates and maltodextrins, and any mixtures of these polymers.
  • the compositions according to the invention comprise 0 to at most 5% by weight of ethanol.
  • compositions according to the invention are essentially anhydrous, ie they contain 0 to at most 6% by weight, preferably 1 to at most 5% by weight, more preferably 2 to at most 4% by weight, free water, in each case based on the total ( propellant-free) composition.
  • the content of water of crystallization, water of hydration or similar molecularly bound Water which may be present in the constituents used, in particular in the antiperspirant active substances, does not constitute free water in the context of the present application.
  • the compositions according to the invention may contain additional deodorants. Antimicrobial, antibacterial or antimicrobial substances, antioxidants or odor adsorbents (eg zinc ricinoleate) can be used as deodorants.
  • Suitable antimicrobial, antibacterial or antimicrobial substances are in particular organohalogen compounds and halides, quaternary ammonium compounds, a series of plant extracts and zinc compounds. Preference is given to halogenated phenol derivatives such.
  • hexachlorophene or Irgasan DP 300 triclosan, 2,4,4'-trichloro-2'-hydroxydiphenyl ether), 3,4,4'-trichlorocarbonyl, chlorhexidine (1, 1'-hexamethylene-bis- [5- (4 -chlorophenyl)] - biguanide), chlorohexadione gluconate, benzalkonium halides and cetylpyridinium chloride.
  • deodorant agents are long chain diols, eg. B.
  • compositions of the invention may be packaged in commercial aerosol cans.
  • the cans can be tinplate or aluminum. Furthermore, the cans can be internally coated to minimize the risk of corrosion.
  • the cans are equipped with a suitable spray head. Depending on the spray head, discharge rates based on fully filled cans of 0.1 g / s to 2.0 g / s are possible.
  • improved of the sweat reduction means both a reduction of the amount of sweat and an acceleration of the release of the antiperspirant active ingredient from the composition according to the invention.
  • a further subject of the present application is the non-therapeutic, cosmetic use of an antiperspirant composition according to claim 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 for reduction and / or regulation of perspiration and / or body odor.
  • compositions according to the invention applies mutatis mutandis.
  • a further subject matter of the present application is a non-therapeutic, cosmetic method for reducing and / or regulating perspiration and / or body odor, in which a composition according to the invention or preferred according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or 15 in an effective amount on the skin, preferably on the skin in the underarm area, is applied.
  • compositions according to the invention applies mutatis mutandis.
  • compositions of the invention No. 1 to No. 6 were applied to the skin in the underarm area.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)

Abstract

L'invention concerne des compositions anti-transpirantes pour l'hygiène corporelle personnelle, sous forme de solution ou suspension pouvant être diffusée avec ou sans gaz propulseur, qui contient au moins une huile fluide en conditions normales comme excipient, un mélange d'acide silicique hydrophile et d'acide silicique hydrophobe comme agent de suspension, 0 à 6 % en poids d'eau libre, par rapport au poids de la composition sans gaz propulseur, au moins un sel d'argent et un ou plusieurs phyllosilicates en quantité totale de 0 à 1,3 % en poids maximum.
PCT/EP2010/057211 2009-06-19 2010-05-26 Sprays anti-transpirants WO2010145923A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE200910027050 DE102009027050A1 (de) 2009-06-19 2009-06-19 Antitranspirant-Sprays
DE102009027050.7 2009-06-19

Publications (2)

Publication Number Publication Date
WO2010145923A2 true WO2010145923A2 (fr) 2010-12-23
WO2010145923A3 WO2010145923A3 (fr) 2011-12-01

Family

ID=43083457

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2010/057211 WO2010145923A2 (fr) 2009-06-19 2010-05-26 Sprays anti-transpirants

Country Status (2)

Country Link
DE (1) DE102009027050A1 (fr)
WO (1) WO2010145923A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102012212531A1 (de) * 2012-07-18 2014-01-23 Beiersdorf Ag Neues kosmetisches Sonnenschutzspray
DE102012212548A1 (de) * 2012-07-18 2014-01-23 Beiersdorf Ag Neustes kosmetisches Sonnenschutzspray
US11186424B2 (en) 2013-07-16 2021-11-30 The Procter & Gamble Company Antiperspirant spray devices and compositions
US20150023886A1 (en) 2013-07-16 2015-01-22 The Procter & Gamble Company Antiperspirant Spray Devices and Compositions
DE102016000190A1 (de) * 2015-07-21 2017-01-26 Beiersdorf Ag Kosmetische Zubereitung enthaltend Polyquaternium-6 und/oder Polyquaternium-16
FR3083091A1 (fr) * 2018-06-29 2020-01-03 L'oreal Composition deodorante sous forme d'aerosol

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595339A2 (fr) * 1992-10-29 1994-05-04 The Gillette Company Composition antiperspirante pour aérosol efficacité
EP0972723A2 (fr) * 1998-07-14 2000-01-19 Toyo Aerosol Industry Co., Ltd. Récipient-aérosol à double chambre et son procédé de fabrication
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2571030A (en) 1950-03-15 1951-10-09 Reheis Company Inc Astringent, antiperspirant, and method of making
US3904741A (en) 1970-10-26 1975-09-09 Armour Pharma Alcohol soluble basic aluminum chlorides and method of making same
CA958338A (en) 1971-03-08 1974-11-26 Chung T. Shin Antiperspirant powder aerosol compositions containing aluminum chloride and water soluble aluminum compounds and methods of preparation
US3887692A (en) 1972-07-10 1975-06-03 Armour Pharma Microspherical basic aluminum halides and method of making same
US4359456A (en) 1976-01-14 1982-11-16 Lever Brothers Company Antiperspirant activity of basic aluminum compounds
GB2048229A (en) 1979-04-20 1980-12-10 Gillette Co Aluminium Chlorhydroxide and Preparation Thereof
US4775528A (en) 1983-08-16 1988-10-04 The Gillette Company Antiperspirant composition
US5643558A (en) 1994-11-02 1997-07-01 The Gillette Company Method of making polyhydric alcohol solutions of enhanced efficacy antiperspirant actives
US6010688A (en) 1997-06-25 2000-01-04 The Gillette Company Polyhydric alcohol stabilized antiperspirant salt solutions
US6042816A (en) 1998-08-19 2000-03-28 The Gillette Company Enhanced antiperspirant salts stabilized with calcium and concentrated aqueous solutions of such salts
US6663854B1 (en) 2002-06-19 2003-12-16 Yan-Fei Shen Aluminum-zirconium antiperspirant salts made with zirconium salts having low Zr:Cl ratio
US6835373B2 (en) 2002-07-12 2004-12-28 The Procter & Gamble Company Non-irritating antiperspirant compositions containing acidic antiperspirant active
US6902723B2 (en) 2003-08-14 2005-06-07 The Gillette Company Enhanced efficacy antiperspirant compositions containing strontium
US20060115440A1 (en) 2004-09-07 2006-06-01 Arata Andrew B Silver dihydrogen citrate compositions
US20060051430A1 (en) 2004-09-07 2006-03-09 Arata Andrew B Silver dihydrogen citrate compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0595339A2 (fr) * 1992-10-29 1994-05-04 The Gillette Company Composition antiperspirante pour aérosol efficacité
EP0972723A2 (fr) * 1998-07-14 2000-01-19 Toyo Aerosol Industry Co., Ltd. Récipient-aérosol à double chambre et son procédé de fabrication
DE202008014407U1 (de) * 2008-07-08 2009-02-05 Beiersdorf Ag Kosmetische Zubereitungen mit passiviertem Silber

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
E. JUNGERMANN: "Antiperspirants: New Trends in Formulation and Testing Technology", J. SOC. COSMET. CHEM., Bd. 25, November 1974 (1974-11), Seiten 621-638, XP002646566, *
HASENZAHL S ET AL: "Fumed silica for personal care and cosmetics-versatile and effective", SOFW-JOURNAL SEIFEN, OELE, FETTE, WACHSE, VERLAG FUR CHEMISCHE INDUSTRIE, AUGSBURG, DE, Bd. 129, Nr. 8, 1. Januar 2003 (2003-01-01), Seiten 22-24,26,28,, XP001539786, ISSN: 0942-7694 *

Also Published As

Publication number Publication date
DE102009027050A1 (de) 2010-12-23
WO2010145923A3 (fr) 2011-12-01

Similar Documents

Publication Publication Date Title
EP2224897B1 (fr) Sprays anti-transpirants sans eau à libération d'agents améliorée
EP2413889B1 (fr) Sprays anti-transpirants sans eau à libération améliorée de substance active
EP2413890A2 (fr) Sprays anti-transpirants contenant des huiles esters
EP2758029A1 (fr) Formulations anhydres présentant un effet de refroidissement
WO2010145923A2 (fr) Sprays anti-transpirants
EP2480192B1 (fr) Anti-transpirants non aérosol sans eau à libération améliorée d'agents
DE102011086019A1 (de) Deodorant- und Antitranspirant-Zusammensetzungen zur Verhinderung von Körpergeruch
DE102017223179B4 (de) Rückstandsminimierte schweißhemmende Zusammensetzung mit verbessertem Hautgefühl
DE102013220779A1 (de) Schweißhemmende kosmetische Mittel mit Lactaten
US11103426B2 (en) Anhydrous, antiperspirant composition having improved stability
DE102015224559B4 (de) "Textil schonende Antitranspirant-Zusammensetzungen"
EP3057666A1 (fr) Agent cosmétique anti-transpiration contenant des acides sulfoniques aromatiques
WO2015055197A1 (fr) Agent cosmétique anti-transpirant contenant des acides polyphosphoriques
EP3057564A1 (fr) Produit cosmétique anti-transpirant contenant des acides amidosulfoniques
EP2705879B1 (fr) Mélange d'huile pour compositions anti-transpirantes à masquage amélioré des sels résiduels
EP3057568B1 (fr) Utilisation de l'acide méthanesulfonique et de ses sels pour l'activation et/ou stabilisation des sels d'aluminium anti-transpirants
WO2010145922A2 (fr) Compositions anti-transpirantes contenant du citrate d'argent
EP3057567A2 (fr) Produits cosmétiques anti-transpirants aux alpha-hydroxyacides
EP2626061A2 (fr) Procédé de fabrication d'un produit cosmétique avec une phase huileuse épaissie

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 10720927

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase in:

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 10720927

Country of ref document: EP

Kind code of ref document: A2